Search

Search Constraints

You searched for: Author/Creator Thomas, David M.

Search Results

2. Who should access germline genome sequencing? A mixed methods study of patient views. Issue 2 (26th November 2019)

3. Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling. Issue 11 (14th July 2021)

4. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. (8th January 2013)

5. Cancer patient knowledge about and behavioral intentions after germline genome sequencing. Issue 3 (March 2022)

6. Value of whole‐genome sequencing to Australian cancer patients and their first‐degree relatives participating in a genomic sequencing study. Issue 1 (3rd July 2021)

7. Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients. Issue 2 (February 2022)

9. Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. (2021)

10. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients. Issue 7 (July 2022)